Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report)’s share price shot up 10% on Monday . The company traded as high as $0.78 and last traded at $0.7270. 656,290 shares traded hands during trading, an increase of 30,214% from the average session volume of 2,165 shares. The stock had previously closed at $0.6610.
Graybug Vision Trading Up 10.0%
The firm has a market cap of $1.14 million, a price-to-earnings ratio of -0.42 and a beta of 1.20. The stock has a 50-day moving average of $2.75 and a 200-day moving average of $3.32.
Graybug Vision Company Profile
Graybug Vision, Inc is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for retinal diseases. The company’s proprietary Depot Technology Platform is designed to deliver sustained-release formulations of biologically active agents directly to the back of the eye, with the goal of reducing treatment burden and improving patient outcomes. Graybug’s lead product candidate, GB-102, is a long-acting formulation of sunitinib malate being investigated for the treatment of wet age-related macular degeneration (wet AMD).
Recommended Stories
- Five stocks we like better than Graybug Vision
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
